ATLANTA, May 8, 2014 /PRNewswire/ -- Alimera Sciences, Inc. /quotes/zigman/117899/delayed/quotes/nls/alim ALIM -0.01% (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
